Full Text Journal Articles by
Author Carrie Printz

Advertisement

Find full text journal articles






Easing the financial burden of cancer on seniors: With many seniors struggling to afford cancer drugs under Medicare, clinicians and advocates are pushing for new laws that limit out-of-pocket expenses.

Carrie Printz,

Cancer (Cancer)
[2020, 126(10):2111-2112]

Cited: 0 times

View full text PDF listing >>



Research teams unite to develop an early detection test for ovarian cancer.

Carrie Printz,

Cancer (Cancer)
[2020, 126(10):2113]

Cited: 0 times

View full text PDF listing >>



Advertisement

Addition of tucatinib to trastuzumab and chemotherapy improves survival for patients with metastatic, HER2-positive breast cancer.

Carrie Printz,

Cancer (Cancer)
[2020, 126(10):2113]

Cited: 0 times

View full text PDF listing >>



Chemotherapy can induce relapse in some patients with leukemia.

Carrie Printz,

Cancer (Cancer)
[2020, 126(8):1601]

Cited: 0 times

View full text PDF listing >>



First person profile: Emil J. Freireich, MD: At age 92, this legendary physician-scientist still inspires students and colleagues to push toward new discoveries.

Carrie Printz,

Cancer (Cancer)
[2020, 126(7):1373-1374]

Cited: 0 times

View full text PDF listing >>



Clinician reminders increase cancer screening orders, but patients need prompts as well.

Carrie Printz,

Cancer (Cancer)
[2020, 126(7):1374-1375]

Cited: 0 times

View full text PDF listing >>



Radiation from computed tomography scans is associated with increased risk for thyroid cancer and leukemia.

Carrie Printz,

Cancer (Cancer)
[2020, 126(8):1601]

Cited: 0 times

View full text PDF listing >>



Hyperprogressive disease observed in a subset of patients treated with immune checkpoint inhibitors: Although clinicians are not questioning the value of immunotherapy, they are struggling with how to define, identify, and treat this uncommon response to it.

Carrie Printz,

Cancer (Cancer)
[2020, 126(8):1599-1600]

Cited: 0 times

View full text PDF listing >>



Rates of anal cancer increase dramatically in the United States.

Carrie Printz,

Cancer (Cancer)
[2020, 126(7):1375]

Cited: 0 times

View full text PDF listing >>



Men who use assistive reproduction appear to have higher prostate cancer risk.

Carrie Printz,

Cancer (Cancer)
[2020, 126(6):1148-1149]

Cited: 0 times

View full text PDF listing >>



Nearly half of patients with cancer who enter a comprehensive treatment program quit smoking.

Carrie Printz,

Cancer (Cancer)
[2020, 126(6):1149]

Cited: 0 times

View full text PDF listing >>



Fighting the teen vaping epidemic: With rates of adolescent vaping on the rise, experts caution that new federal rules targeting e-cigarettes may not be strong enough.

Carrie Printz,

Cancer (Cancer)
[2020, 126(6):1147-1148]

Cited: 0 times

View full text PDF listing >>



First person profile: Dennis J. Slamon, MD, PhD: Dr. Slamon's pioneering work helped lead to the breakthrough breast cancer drug trastuzumab, which has saved and extended the lives of millions of patients.

Carrie Printz,

Cancer (Cancer)
[2020, 126(5):919-920]

Cited: 0 times

View full text PDF listing >>



American Indian and Alaska Native populations face a higher risk of many types of cancer.

Carrie Printz,

Cancer (Cancer)
[2020, 126(5):921]

Cited: 0 times

View full text PDF listing >>



New research finds lung cancer screening guidelines are insufficient for firefighters.

Carrie Printz,

Cancer (Cancer)
[2020, 126(4):692-693]

Cited: 0 times

View full text PDF listing >>



Low-income, Asian American women benefit from human papillomavirus self-sampling tests.

Carrie Printz,

Cancer (Cancer)
[2020, 126(3):469]

Cited: 0 times

View full text PDF listing >>



Experts say more women should be tested for BRCA1 and BRCA2 genetic mutations.

Carrie Printz,

Cancer (Cancer)
[2020, 126(4):693]

Cited: 0 times

View full text PDF listing >>



First person profile: Sir Murray Brennan, MD: A legendary surgical oncologist, Dr. Brennan's research on soft tissue sarcomas and his willingness to mentor others have left a mark on the field.

Carrie Printz,

Cancer (Cancer)
[2020, 126(3):467-468]

Cited: 0 times

View full text PDF listing >>



A more effective approach to lung cancer screening?: Researchers have developed a new risk prediction model to help inform patients and their physicians whether they should undergo lung cancer screening and, if so, when.

Carrie Printz,

Cancer (Cancer)
[2020, 126(4):691-692]

Cited: 0 times

View full text PDF listing >>



Study finds that women with posttraumatic stress disorder have an increased risk of ovarian cancer.

Carrie Printz,

Cancer (Cancer)
[2020, 126(3):468-469]

Cited: 0 times

View full text PDF listing >>



Patients with operable HER2-positive breast cancer appear to benefit from the addition of pertuzumab to trastuzumab plus chemotherapy.

Carrie Printz,

Cancer (Cancer)
[2020, 126(9):1827]

Cited: 0 times

View full text PDF listing >>



Precision medicine for pediatric cancers lags behind that for adult cancers: Citing hurdles in clinical trial recruitment and drug development, researchers are exploring ways to close gaps.

Carrie Printz,

Cancer (Cancer)
[2020, 126(2):239-240]

Cited: 0 times

View full text PDF listing >>



First person profile: Dr. Thomas Smith: A renowned palliative care expert, Dr. Smith has dedicated his career to ensuring that patients with advanced cancer receive the best possible symptom management and support.

Carrie Printz,

Cancer (Cancer)
[2020, 126(1):11-13]

Cited: 0 times

View full text PDF listing >>



First person profile: Leslie L. Robison, PhD: A world-renowned epidemiologist, Dr. Robison played key roles in developing both the national Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort Study.

Carrie Printz,

Cancer (Cancer)
[2020, 126(9):1825-1826]

Cited: 0 times

View full text PDF listing >>



Psychological stress is associated with a higher risk of cervical cancer mortality.

Carrie Printz,

Cancer (Cancer)
[2020, 126(2):240-241]

Cited: 0 times

View full text PDF listing >>



Advertisement

Disclaimer
0.7489 s